DEA Addiction Medicine Essentials-263576

Video Transcription

Video Summary

The presentation by Dr. Gregory Landy covers stimulant use disorders, specifically focusing on cocaine, amphetamines, methamphetamines, and synthetic cathinones (bath salts) as per DSM-5 criteria. Dr. Landy outlines the diagnostic criteria, emphasizing the need for clinically significant impairment due to stimulant use. He reviews the epidemiology based on the National Survey on Drug Use and Health, highlighting trends in usage and use disorders across different age groups.<br /><br />The presentation further discusses the street names, forms, and methods of usage for each substance, as well as their short-term and long-term health impacts. While stimulant use can lead to euphoria and increased energy, it also has severe health implications, including cardiovascular issues, tooth decay, and neurological effects. Despite the profound effects, there are no FDA-approved medications for treating stimulant use disorders.<br /><br />For treatment, Dr. Landy emphasizes evidence-based behavioral therapies such as motivational interviewing, contingency management, community reinforcement, and cognitive behavioral therapy. Each method aims to reduce stimulant use and improve lifestyle. Lastly, he mentions ongoing research in pharmacotherapy, although no definitive medication is yet endorsed for stimulant disorders. The presentation includes numerous references for deeper exploration of the topics.

Keywords

stimulant use disorders

cocaine

methamphetamines

synthetic cathinones

DSM-5 criteria

behavioral therapies

epidemiology

health impacts

pharmacotherapy